The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More

The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
The quest to miniaturize photonic devices to the scale of modern electronic circuits has long been stymied by the fundamental…
Read More
Developing treatments for the approximately 7,000 known rare diseases, particularly the subset classified as ultra-rare, presents profound and often insurmountable…
Read More
The pursuit of clean, limitless energy through nuclear fusion and the understanding of the most violent phenomena in the universe…
Read More
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
The research, spearheaded by Professor Mingxin Huang, marks a pivotal moment in materials science. By utilizing a "sequential dual-passivation" strategy,…
Read More
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the inherent limitations of traditional…
Read More
In a landmark achievement for high-energy-density physics, researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have successfully documented the instantaneous ionization of…
Read More
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
In the vast, silent expanse of the cosmos, particles of nearly inconceivable energy occasionally strike the Earth’s atmosphere, leaving scientists…
Read More